Skip to main content

TB activists challenge TB drug patent in India

You are here

TB activists for first time challenge TB drug patent in India, in bid to prevent J&J from extending monopoly

MSF is supporting a patent challenge filed in India by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson from extending its monopoly on the tuberculosis drug bedaquiline.